| Entry |
|
|---|
| Name |
Carperitide (USAN/INN);
Carperitide (genetical recombination) (JAN);
Hanp (TN) |
|---|
| Formula |
C127H203N45O39S3
|
|---|
| Exact mass |
3078.4447
|
|---|
| Mol weight |
3080.45
|
|---|
| Sequence |
Ser Leu Arg Arg Ser Ser Cys Phe Gly Gly Arg Met Asp Arg Ile Gly
Ala Gln Ser Gly Leu Gly Cys Asn Ser Phe Arg Tyr
(Disulfide bridge: 7-23) |
|---|
| Type |
Peptide |
|---|
| Remark |
| Therapeutic category: | 2179 |
|
|---|
| Efficacy |
Vasodilator, Atrial natriuretic peptide receptor agonist |
|---|
| Comment |
Recombinant of human alpha atrial natriuretic polypeptide (ANP) [HSA: 4878]
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04270 | Vascular smooth muscle contraction |
|
|---|
| Interaction |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
217 Vasodilators
2179 Others
D03328 Carperitide (USAN/INN); Carperitide (genetical recombination) (JAN)
Target-based classification of drugs [BR:br08310]
Enzymes
Lyases (EC4)
Phosphorus-oxygen lyases
NPR1
D03328 Carperitide (USAN/INN) <JP>
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
